ETV1 and breast cancer: The activator for the thyroid and retinoic acid receptor is over-expressed in approximately 60% of breast cancers and it has been reported to “cooperate” with her-2-neu, a breast oncogene associated with aggressive tumor, in dysregulation of transcription factor ER81 (Goel and Janknecht, 2004).